NYSE American - Nasdaq Real Time Price USD

InfuSystem Holdings, Inc. (INFU)

7.18 +0.05 (+0.63%)
As of 10:03 AM EDT. Market Open.
Loading Chart for INFU
DELL
  • Previous Close 7.14
  • Open 7.23
  • Bid 7.13 x 800
  • Ask 7.24 x 1000
  • Day's Range 7.18 - 7.30
  • 52 Week Range 6.25 - 11.44
  • Volume 10,574
  • Avg. Volume 52,666
  • Market Cap (intraday) 153.007M
  • Beta (5Y Monthly) 1.29
  • PE Ratio (TTM) 718.50
  • EPS (TTM) 0.01
  • Earnings Date Aug 1, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

www.infusystem.com

499

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INFU

Performance Overview: INFU

Trailing total returns as of 6/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INFU
31.83%
S&P 500
10.77%

1-Year Return

INFU
21.22%
S&P 500
23.37%

3-Year Return

INFU
60.82%
S&P 500
25.55%

5-Year Return

INFU
46.63%
S&P 500
91.98%

Compare To: INFU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INFU

Valuation Measures

Annual
As of 5/31/2024
  • Market Cap

    152.05M

  • Enterprise Value

    186.49M

  • Trailing P/E

    714.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.22

  • Price/Book (mrq)

    2.91

  • Enterprise Value/Revenue

    1.46

  • Enterprise Value/EBITDA

    12.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.07%

  • Return on Assets (ttm)

    2.02%

  • Return on Equity (ttm)

    0.17%

  • Revenue (ttm)

    127.41M

  • Net Income Avi to Common (ttm)

    84k

  • Diluted EPS (ttm)

    0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    822k

  • Total Debt/Equity (mrq)

    70.39%

  • Levered Free Cash Flow (ttm)

    8.19M

Research Analysis: INFU

Company Insights: INFU

Research Reports: INFU

People Also Watch